AcuCort plans rights issue of up to SEK 70.3 million to fund Zeqmelit FDA push

Bitget2026/10/05 06:51

AcuCort’s board resolved to launch a rights issue of up to 78,148,177 units, aiming to raise about SEK 70.3 million initially. Units priced at SEK 0.90 include three shares and two TO 3 warrants; TO 3 could add up to SEK 93.8 million. Funding package includes about SEK 52.8 million in subscription undertakings and underwriting commitments, covering roughly 75% of the issue. A SEK 5 million bridge loan was raised to cover funding needs until completion; the rights issue awaits shareholder approval on Nov. 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AcuCort’s board resolved to launch a rights issue of up to 78,148,177 units, aiming to raise about SEK 70.3 million initially.
Units priced at SEK 0.90 include three shares and two TO 3 warrants; TO 3 could add up to SEK 93.8 million.
Funding package includes about SEK 52.8 million in subscription undertakings and underwriting commitments, covering roughly 75% of the issue.
A SEK 5 million bridge loan was raised to cover funding needs until completion; the rights issue awaits shareholder approval on Nov. 5, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Incordex appointed Chen Wang to its board effective Sept. 29, 2026. Wang founded his own brand. He has served as founder and board chairman of Yunnan Jinshengchang Technology and Trade since Oct. 2024. He previously led global pharmaceutical education operations at Meixin E-commerce. He later ran education operations at Zhuyuan Grop. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incordex Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-006080), on October 07, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/07 16:03